These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33384330)
21. Excitatory and inhibitory D-serine binding to the NMDA receptor. Yovanno RA; Chou TH; Brantley SJ; Furukawa H; Lau AY Elife; 2022 Oct; 11():. PubMed ID: 36301074 [TBL] [Abstract][Full Text] [Related]
22. Desensitization of NMDA channels requires ligand binding to both GluN1 and GluN2 subunits to constrict the pore beside the activation gate. Chen YS; Tu YC; Lai YC; Liu E; Yang YC; Kuo CC J Neurochem; 2020 Jun; 153(5):549-566. PubMed ID: 31821563 [TBL] [Abstract][Full Text] [Related]
23. Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors. Wang H; Lv S; Stroebel D; Zhang J; Pan Y; Huang X; Zhang X; Paoletti P; Zhu S Neuron; 2021 Aug; 109(15):2443-2456.e5. PubMed ID: 34186027 [TBL] [Abstract][Full Text] [Related]
24. Structural Basis of Functional Transitions in Mammalian NMDA Receptors. Chou TH; Tajima N; Romero-Hernandez A; Furukawa H Cell; 2020 Jul; 182(2):357-371.e13. PubMed ID: 32610085 [TBL] [Abstract][Full Text] [Related]
25. Glutamate and Glycine Binding to the NMDA Receptor. Yu A; Lau AY Structure; 2018 Jul; 26(7):1035-1043.e2. PubMed ID: 29887499 [TBL] [Abstract][Full Text] [Related]
26. The LILI Motif of M3-S2 Linkers Is a Component of the NMDA Receptor Channel Gate. Ladislav M; Cerny J; Krusek J; Horak M; Balik A; Vyklicky L Front Mol Neurosci; 2018; 11():113. PubMed ID: 29681798 [TBL] [Abstract][Full Text] [Related]
27. GluN1 splice variant control of GluN1/GluN2D NMDA receptors. Vance KM; Hansen KB; Traynelis SF J Physiol; 2012 Aug; 590(16):3857-75. PubMed ID: 22641781 [TBL] [Abstract][Full Text] [Related]
28. Single-Molecule Patch-Clamp FRET Anisotropy Microscopy Studies of NMDA Receptor Ion Channel Activation and Deactivation under Agonist Ligand Binding in Living Cells. Sasmal DK; Yadav R; Lu HP J Am Chem Soc; 2016 Jul; 138(28):8789-801. PubMed ID: 27270213 [TBL] [Abstract][Full Text] [Related]
37. Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. Hansen KB; Ogden KK; Traynelis SF J Neurosci; 2012 May; 32(18):6197-208. PubMed ID: 22553026 [TBL] [Abstract][Full Text] [Related]
38. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors. Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999 [TBL] [Abstract][Full Text] [Related]
39. Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors. Dravid SM; Burger PB; Prakash A; Geballe MT; Yadav R; Le P; Vellano K; Snyder JP; Traynelis SF J Neurosci; 2010 Feb; 30(7):2741-54. PubMed ID: 20164358 [TBL] [Abstract][Full Text] [Related]
40. Correlated conformational dynamics of the human GluN1-GluN2A type N-methyl-D-aspartate (NMDA) receptor. Essiz S; Gencel M; Aktolun M; Demir A; Carpenter TS; Servili B J Mol Model; 2021 May; 27(6):162. PubMed ID: 33969428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]